ZAG (zinc-alpha2-glycoprotein) - adipokine, may participate in the mechanism of malnutrition in chronic kidney disease (CKD) as cachexia factor. The transmembrane protein of the endoplasmic reticulum - lipase maturation factor 1 (LMF1) is necessary for the secretion and enzymatic activity of lipases and lowering triglycerides level. The aim of the study was to evaluate these markers - ZAG and LMF1, their potential importance in CKD in children. The study included 59 children and adolescents aged 10.7±5.0 years with CKD. Compared with healthy children, serum and urine ZAG levels were higher in children with CKD. A similar relationship was obtained in the comparison of girls and boys between the above groups. We showed a reduced serum and urine concentration of LMF1 in children with CKD. Additionally, ZAG and LMF1 levels in children below 10 years of age and above 10 were no different. There was also no correlation between these markers and serum creatinine (except negative correlation of urinary ZAG), albumin, cholesterol, triglycerides. LMF1 concentration correlated positively with vitamin D level in dialyzed patients. To conclude, elevated serum ZAG levels in children with CKD document that selective kidney damage results in the rise of ZAG concentration, however the specific role of this marker in malnutrition was not documented. Reduced serum LMF1 concentration in children with CKD, did not correlate with standard parameters used to assess lipid metabolism and severity of CKD. The usefulness of LMF1 as the marker of the lipid metabolism disturbances in children with CKD was not proven.

Pediatric Nephrology Ward Independent Public Clinical Hospital No 1 in Zabrze Poland

See more in PubMed

ARFIAN N, KUSUMA MH, ANGGOROWATI N, NUGROHO DB, JEFFILANO A, SUZUKI Y, IKEDA K, EMOTO N. Vitamin D upregulates endothelin-1, ETBR, eNOS mRNA expression and attenuates vascular remodelling and ischemia in kidney fibrosis model in mice. Physiol Res. 2018;67(Suppl 1):S137–S147. doi: 10.33549/physiolres.933823. PubMed DOI

BABILONIA-ROSA MA, NEHER SB. Purification, cellular levels, and functional domains of lipase maturation factor 1. Biochem Biophys Res Commun. 2014;450:423–428. doi: 10.1016/j.bbrc.2014.05.136. PubMed DOI PMC

BING C, MRACEK T, GAO D, TRAYHURN P. Zinc-a2-glycoprotein: an adipokine modulator of body fat mass? Int J Obes (Lond) 2010;34:1559–1565. doi: 10.1038/ijo.2010.105. PubMed DOI

BOUCHARA A, DAN YI, PASTURAL M, GRANJON S, SELAG JC, LAVILLE M, ARKOUCHE W, PELLETIER S, FOUQUE D, SOULAGE CO, KOPPE L. Serum levels of the adipokine zinc-alpha2-glycoprotein (ZAG) predict mortality in hemodialysis patients. Kidney Int. 2018;94:983–992. doi: 10.1016/j.kint.2018.07.019. PubMed DOI

CARRERO JJ, STENVINKEL P, FELLSTRÖM B, QURESHI AR, LAMB K, HEIMBÜRGER O, BÁRÁNY P, RADHAKRISHNAN K, LINDHOLM B, SOVERI I, NORDFORS L, SHIELSPG Telomere attrition is associated with inflammation, low fetuin-A levels and high mortality in prevalent haemodialysis patients. J Intern Med. 2008;263:302–312. doi: 10.1111/j.1365-2796.2007.01890.x. PubMed DOI

COLLINS AJ, FOLEY R, HERZOG C, CHAVERS B, GILBERTSON D, ISHANI A, KASISKE B, LIU J, MAU LW, MCBEAN M, MURRAY A, PETER WS, XUE J, FAN Q, GUO H, LI Q, LI S, PENG Y, QIU Y, ROBERTS T, SKEANS M, SNYDER J, SOLID C, WANG C, WEINHANDL E, ZAUN D, ZHANG R, ARKO C, CHEN SC, DALLESKA F, DANIELS F, DUNNING S, EBBEN J, FRAZIER E, HANZLIK C, JOHNSON R, SHEETS D, WANG X, FORREST B, CONSTANTINI E, EVERSON S, EGGERS P, AGODOAL Excerpts from the United States Renal Data System 2007 annual data report. Am J Kidney Dis. 2008;51(Suppl 1):S1–S320. doi: 10.1053/j.ajkd.2007.11.001. PubMed DOI

DE SIMONE G, DANIELS SR, DEVEREUX RB, MEYER RA, ROMAN MJ, DE DIVITIIS O, ALDERMAN MH. Left ventricular mass and body size in normotensive children and adults: Assessment of allometric relations and impact of overweight. J Am Coll Cardiol. 1992;20:1251–1260. doi: 10.1016/0735-1097(92)90385-Z. PubMed DOI

DEVEREUX RB, ALONSO DR, LUTAS EM, GOTTLIEB GJ, CAMPO E, SACHS I, REICHEK N. Echocardiographic assessment of left ventricular hypertrophy: Comparison to necropsy findings. Am J Cardiol. 1986;57:450–458. doi: 10.1016/0002-9149(86)90771-X. PubMed DOI

GAMROT Z, ADAMCZYK P, ŚWIĘTOCHOWSKA E, ROSZKOWSKA-BJANID D, GAMROT J, SZCZEPAŃSKA M. Fibroblast growth factor 21 (FGF21) in children and adolescents with chronic kidney disease. Physiol Res. 2020;69:451–460. doi: 10.33549/physiolres.934307. PubMed DOI PMC

GROOTHOFF JW, GRUPPEN MP, OFFRINGA M, HUTTEN J, LILIEN MR, VAN DE KAR NJ, WOLFF ED, DAVIN JC, HEYMANS HS. Mortality and causes of death of end-stage renal disease in children: a Dutch cohort study. Kidney Int. 2002;61:621–629. doi: 10.1046/j.1523-1755.2002.00156.x. PubMed DOI

JARZUMBEK A. PhD Thesis. Medical University of Silesia; Katowice: 2017. The evaluation of serum MIC-1 and ZAG/LMF in girls with anorexia nervosa.

KOOMAN JP, BROERS NJ, USVYAT L, THIJSSEN S, VAN DER SANDE FM, CORNELIS T, LEVIN NW, LEUNISSEN KM, KOTANKO P. Out of control: accelerated aging in uremia. Nephrol Dial Transplant. 2013;28:48–54. doi: 10.1093/ndt/gfs451. PubMed DOI

KOOMAN JP, KOTANKO P, SCHOLS AM, SHIELSPG, STENVINKEL P. Chronic kidney disease and premature ageing. Nat Rev Nephrol. 2014;10:732–742. doi: 10.1038/nrneph.2014.185. PubMed DOI

KURITA S, TAKEUCHI K, HAYASHI Y, UEYAMA H, ZANKOV DP, PANG X, OTSUKA T, OHKUBO I, OGIKUBO O, OGITA H. Significance of serum Zn-α2-glycoprotein for the regulation of blood pressure. Hypertens Res. 2015;38:244–251. doi: 10.1038/hr.2014.165. PubMed DOI

LEAL VO, LOBO JC, STOCKLER-PINTO MB, FARAGE NE, VELARDE GC, FOUQUE D, LEITE M, JR, MAFRA D. Is zinc-a2-glycoprotein a cardiovascular protective factor for patients undergoing hemodialysis? Clin Chim Acta. 2012;413:616–619. doi: 10.1016/j.cca.2011.12.002. PubMed DOI

MCDONALD SP, CRAIG JC. Long-term survival of children with end-stage renal disease. N Engl J Med. 2004;350:2654–2662. doi: 10.1056/NEJMoa031643. PubMed DOI

MAK RH, IKIZLER AT, KOVESDY CP, KOVESDY CP, RAJ DS, STENVINKEL P, KALANTAR-ZADEH K. Wasting in chronic kidney disease. J Cachexia Sarcopenia Muscle. 2011;2:9–25. doi: 10.1007/s13539-011-0019-5. PubMed DOI PMC

MIAN AN, SCHWARTZ GJ. Measurement and estimation of glomerular filtration rate in children. Adv Chronic Kidney Dis. 2017;24:348–356. doi: 10.1053/j.ackd.2017.09.011. PubMed DOI PMC

NATIONAL KIDNEY FOUNDATIONK/DOQI Clinical Practice Guidelines for Chronic Kidney Disease. Evaluation, Classification, and Stratification. February Supplement 1. Am J Kidney Dis. 2002;39(Suppl 1):S1–S266. PubMed

OH J, WUNSCH R, TURZER M, BAHNER M, RAGGI P, QUERFELD U, MEHLS O, SCHAEFER F. Advanced coronary and carotid arteriopathy in young adults with childhood-onset chronic renal failure. Circulation. 2002;106:100–105. doi: 10.1161/01.CIR.0000020222.63035.C0. PubMed DOI

PELLETIER CC, KOPPE L, ALIX PM, KALBACHER E, CROZE ML, HADJ-AISSA A, FOUQUE D, GUEBRE-EGZIABHER F, SOULAGE CO. The relationship between renal function and plasma concentration of the cachectic factor zinc-alpha2-glycoprotein (ZAG) in adult patients with chronic kidney disease. PLoS ONE. 2014;9:e0103475. doi: 10.1371/journal.pone.0103475. PubMed DOI PMC

PLENGPANICH W, MUANPETCH S, CHAROEN S, KIATEPRUNGVEJ A, KHOVIDHUNKIT W. Genetic and functional studies of the LMF1 gene in Thai patients with severe Hypertriglyceridemia. Mol Genet Metab Rep. 2020;23:e100576. doi: 10.1016/j.ymgmr.2020.100576. PubMed DOI PMC

POLEDNE R, KRÁLOVÁLESNÁI,ČEJKOVÁ S. Adipose tissue and atherosclerosis. Physiol Res. 2015;64(Suppl 3):S395–S402. doi: 10.33549/physiolres.933152. PubMed DOI

SHLIPAK MG, DAY EC. Biomarkers for incident CKD: a new framework for interpreting the literature. Nat Rev Nephrol. 2013;9:478–483. doi: 10.1038/nrneph.2013.108. PubMed DOI

STENVINKELP, LARSSON T. Chronic kidney disease: a clinical model of premature aging. Am J Kidney Dis. 2013;62:339–351. doi: 10.1053/j.ajkd.2012.11.051. PubMed DOI

TADA T, OHKUBO I, NIWA M, SASAKI M, TATEYAMA H, EIMOTO TJ. Immunohistochemical localization of Zn-alpha 2-glycoprotein in normal human tissues. Histochem Cytochem. 1991;39:1221–1226. doi: 10.1177/39.9.1918940. PubMed DOI

WANG Y, LI YM, ZHANG S, ZHAO JY, LIU CY. Adipokine zinc-alpha-2-glycoproteinas a novel urinary biomarker presents earlier than micro albuminuria in diabetic nephropathy. J Int Med Res. 2016;44:278–286. doi: 10.1177/0300060515601699. PubMed DOI PMC

WOŹNY ŁA, MORAWIECKA-PIETRZAK M, JASZCZURA M, ZIORA K, GRZESZCZAK W. The new adipokine zinc-α2-glycoprotein (ZAG) as a link between adipose tissue and kidney? Endokrynol Pol. 2019;70:171–189. doi: 10.5603/EP.a2018.005. PubMed DOI

ZHOU J, QIN G. Adipocyte dysfunction and hypertension. Am J Cardiovasc Dis. 2012;2:143–149. PubMed PMC

ZHU HJ, WANG XQ, PAN H, GONG FY, ZHANG DX, LI NS, WANG LJ, YANG HB. Serum levels of the adipokine zinc-2-glycoprotein are decreased in patients with hypertension. ISRN Endocrinology. 2014:e374090. doi: 10.1155/2014/374090. PubMed DOI PMC